Table 2.
study groups | seroprevalence of T. gondii with positive antibody (%) | ||
---|---|---|---|
IgG | IgM | IgM +IgG | |
blood donors | 18 (8 -43) | 2 (1-2) | 33 (29-38) |
Immunocompromised patients | 48 (31-66) | 2 (1-5) | 42 (34-49) |
childbearing age women | 34 (28 -39) | 5 (4-6) | 32 (26-38) |
general population | - | - | 42 (38-45) |
newborns and children | - | - | 4 (2-5) |
pregnant women | 29 (10-48) | 4(3-5) | 40 (37-44) |
overall | 35 (24-47) | 4 (3-5) | 36 (24-48) |